Recall Issued for Popular Anti-Anxiety Drug Alprazolam

According to the FDA, Mylan Pharmaceuticals Inc. has issued a voluntary nationwide recall of Alprazolam Tablets with lot # 8082708. This particular lot is being recalled due to the potential presence of a foreign substance although the FDA does not specify what that substance is. According to the FDA:

Mylan has notified its distributors and customers by letter and is arranging for return of all recalled products. Following are actions for wholesalers, retailers and consumers:

• Wholesaler: Immediately examine your inventory, quarantine and discontinue distribution of these lots. In addition, if you have further distributed the product, please identify your retail level customers and provide a list of customers via Microsoft excel file to mylan5924@stericycle.com within 10 business days. Stericycle will notify your retail level customers that received the affected batches.
• Retailer: Immediately examine your inventory, quarantine and discontinue distribution of these lots. Additionally, if you have further distributed the product, please identify the consumer and notify them immediately of this product recall. The consumer should be instructed to contact Stericycle at 1-888-843-0255 for the documentation packet to return the product.
• Consumer: Please contact Stericycle at 1-888-843-0255 for the documentation packet to return product to Stericycle.

Consumers with questions about this recall may contact Mylan Customer Relations at 800-796-9526 or email customer.service@mylan.com, Monday through Friday from 8 a.m. – 5 p.m. EST. Consumers should also contact their physician or healthcare provider if they experience any problems that may be related to using this drug product.